Are sigma receptor modulators a weapon against multiple sclerosis disease?
This perspective, brought to MedChemNet users by our sister journal, Future Medicinal Chemistry, discusses the potential use of sigma receptor modulators to treat multiple sclerosis.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.